Inhibitors of Akt activity

Details Inhibitors of Akt activity Inhibitors of Akt activity

2007-05-29

2007-05-29

Tucker, Zachary C (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S249000, C514S263220, C514S314000, C536S017400, C536S029200, C544S277000, C544S350000, C546S173000

Reexamination Certificate

active

10510069

ABSTRACT:
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

REFERENCES:
patent: 4760006 (1988-07-01), Pawlowski
patent: 5972937 (1999-10-01), Gaster et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 7034026 (2006-04-01), Barnett et al.
patent: 2002/0127214 (2002-09-01), Hemmings
patent: 2004/0143117 (2004-07-01), Barnett et al.
patent: 0 397 859 (1990-11-01), None
patent: 1384713 (1963-11-01), None
patent: 2 293 380 (1996-03-01), None
patent: 166761 (1988-04-01), None
patent: 64-57261 (1989-01-01), None
patent: 200309578 (2000-11-01), None
patent: WO 96/23783 (1996-08-01), None
patent: WO 97/22360 (1997-06-01), None
patent: WO 99/42461 (1999-08-01), None
patent: WO 99/42463 (1999-08-01), None
patent: WO 01/91754 (2001-12-01), None
patent: WO 02/50065 (2002-06-01), None
patent: WO 03/051366 (2003-06-01), None
Hanada et al, “Structure regulation and function of PKB/AKT—a major therapeutic target” Biochimica et Biophysica Acta vol. 1697, pp. 3-16 (2004).
Gerlicz et al., Rocz. Chem., 51:1087-1093 (1977).
Kraska et al. Pol. J. Chem., 52(9):1665-1674 (1978).
Akutsu et al., Polym. Commun., 30(6):182-183 (1989).
Akutsu et al., J. Appl. Polym. Sci., 69(9):1737-1741 (1998).
*Wang et al., Gaofenzi Tongzun, 4:300-304 (1984).
Venugopalan et al.,Indian J. Chem., 29B:364-365 (1990).
Venugopalan et al., Eur. J. Med. Chem., 24:611-614 (1989).
Chem. Abstract, vol. 63, No. 1, Abstract No. 183B, Kalle, A.G., 1965.
Nakatani et al.,J. Biol. Chem., 274:21528-21532 (1999).
Shiojima and Walsh, Cir. Res., 90:1243-1250 (2002).
Bellacosa et al., Int. J. Cancer, 64:280-285 (1995).
Gilman, J. Amer. Chem. Soc., 70:2619- (1948).
Stambolic et al., Cell, 95:29-39 (1998).
Chem. Abstract, vol. III, No. 14, Abstract No. 123785c, Ishibashi, S.P., 582, 1989.
Cheng et al., Proc. Natl. Acad. Sci. U.S.A., 93:3636-3641 (1996).
Cheng et al., Proc. Natl. Acad. Sci. U.S.A., 89:9267-9271 (1992).
Downward, Curr. Opin. Cell Biol., 10:262-267 (1998).
Venugopalan, et al., Indian J. of Chem., vol. 30B, pp. 777-783, (1991).

Affiliated with

Also associated with

Rating

Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3751193